US Food and Drug Administration FDA adds a Boxed Warning for added risk of mortality with gout prescription drug Uloric febuxostat

From Hikvision Guides
Jump to: navigation, search

conduct a large postmarket safety clinical trial. uloric lawsuit was conducted in over 6,000 patients with gout treated with either Uloric or allopurinol. The main outcome was a combination of heart-related death, non-deadly heart attack, non-deadly stroke, and an issue of inadequate blood supply to the heart requiring intervention, called unstable angina.

Does Your Case Qualify for an Action Against the Manufacturers of Uloric? According to the new Black Box warnings required by the FDA, use of Uloric may elevate the chances of experiencing one of the following conditions:

Death

Heart Attack

Stroke

Pulmonary Embolism (PE)

Deep Vein Thrombosis (DVT)

If you or a loved one has experienced any of the above while taking Uloric for the treatment of gout, you may be entitled to a settlement from Takeda Pharmaceuticals, as well as for expenses, emotional distress, and inconveniences you have endured as a result of your medical treatment.

The attorneys at The Meneo Law Group not only have the skill, experience, and expertise to handle your Uloric lawsuit, but a proven track record of success in representing people, like you, that have been injured by dangerous drugs and products.